the quantification in plasma and urine of 2-dicyclopropylmethylamino-2-oxazoline ( s-3341 ) , a new antihypertensive drug is described using a sensitive gas chromatographic negative ion mass spectrometric method with ammonia as moderating gas .
C0002607
ammonia
C0017110
gas